WHO Archive

WHO appeals for USD 10.2 million to support critical health interventions in Cox’s Bazar, Bangladesh

Cox’s Bazar, Bangladesh, 6 October 2017: The World Health Organization is seeking USD 10.2 million to protect, promote and secure the health of more than half a million people who have moved to southern Bangladesh from across the border since August this year. “The health needs of this immensely vulnerable population are massive, and growing.

New vision and strengthened partnership for WHO and China

21 August 2017 | GENEVA – WHO Director-General Tedros Adhanom Ghebreyesus concluded a 3-day official visit to the People’s Republic of China paving the way for stronger and more strategic WHO-China collaborations. Outcomes of Dr Tedros’ meetings with high-level leadership in the Government of China included a new financial contribution to WHO from China and

Babies and mothers worldwide failed by lack of investment in breastfeeding

New analysis shows an investment of US$4.70 per newborn could generate US$300 billion in economic gains by 2025. 1 August 2017 | GENEVA/NEW YORK – No country in the world fully meets recommended standards for breastfeeding, according to a new report by UNICEF and WHO in collaboration with the Global Breastfeeding Collective, a new initiative

WHO urges action against HIV drug resistance threat

20 July 2017 | GENEVA: The World Health Organization (WHO) alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action

WHO estimates cost of reaching global health targets by 2030

17 JULY 2017 | GENEVA – The SDG Health Price Tag, published today in The Lancet Global Health, estimates the costs and benefits of progressively expanding health services in order to reach 16 Sustainable Development Goal (SDG) health targets in 67 low- and middle-income countries that account for 75% of the world’s population. The analysis

Antibiotic-resistant gonorrhoea on the rise; need for new drugs

7 July 2017 | GENEVA – Data from 77 countries show that antibiotic resistance is making gonorrhoea—a common sexually-transmitted infection—much harder, and sometimes impossible, to treat. “The bacteria that cause gonorrhoea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them,” said Dr

WHO declares the end of Ebola virus disease (EVD) the Democratic Republic of Congo (DRC)

Brazzaville/Kinshasa, 2 July 2017 – Today, the World Health Organization (WHO) declared the end of the most recent outbreak of Ebola virus disease (EVD) in the Democratic Republic of Congo (DRC). The announcement comes 42 days (two 21-day incubation cycles of the virus) after the last confirmed Ebola patient in the affected Bas-Uélé province tested

Abuse of older people on the rise – 1 in 6 affected: WHO

14 June  2017 | GENEVA – Around 1 in 6 older people experience some form of abuse, a figure higher than previously estimated and predicted to rise as populations age worldwide. A new study, supported by WHO and published in the Lancet Global Health, has found that almost 16% of people aged 60 years and

WHO updates Essential Medicines List with new advice on use of antibiotics, and adds medicines for hepatitis C, HIV, TB and cancer

6 JUNE 2017 | GENEVA – New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the World Health Organization’s (WHO’s) Model List of Essential Medicines for 2017. Other additions include medicines for HIV, hepatitis C, tuberculosis and leukaemia. The updated

WHO to begin pilot prequalification of biosimilars for cancer treatment

4 May 2017 | Geneva – This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries. In September, WHO will invite manufacturers to submit applications for prequalification of biosimilar versions of two products